Published in J Biol Chem on August 21, 2009
Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore. J Med Chem (2010) 2.12
Docking flexible ligands in proteins with a solvent exposure- and distance-dependent dielectric function. J Comput Aided Mol Des (2010) 1.15
Identification of new batrachotoxin-sensing residues in segment IIIS6 of the sodium channel. J Biol Chem (2011) 1.00
Structural Basis for Pharmacology of Voltage-Gated Sodium and Calcium Channels. Mol Pharmacol (2015) 0.90
Structural basis for inhibition of a voltage-gated Ca(2+) channel by Ca(2+) antagonist drugs. Nature (2016) 0.90
Potassium channel block by a tripartite complex of two cationophilic ligands and a potassium ion. Mol Pharmacol (2010) 0.89
Verapamil block of T-type calcium channels. Mol Pharmacol (2010) 0.87
A homology model of the pore domain of a voltage-gated calcium channel is consistent with available SCAM data. J Gen Physiol (2010) 0.86
Ca²⁺ channels and praziquantel: a view from the free world. Parasitol Int (2012) 0.85
Structural modeling of calcium binding in the selectivity filter of the L-type calcium channel. Eur Biophys J (2010) 0.83
Functional, electrophysiological and molecular docking analysis of the modulation of Cav 1.2 channels in rat vascular myocytes by murrayafoline A. Br J Pharmacol (2015) 0.75
PKC independent inhibition of voltage gated calcium channels by volatile anesthetics in freshly isolated vascular myocytes from the aorta. Cell Calcium (2013) 0.75
In vitro and in silico analysis of the vascular effects of asymmetrical N,N-bis(alkanol)amine aryl esters, novel multidrug resistance-reverting agents. Naunyn Schmiedebergs Arch Pharmacol (2016) 0.75
Augmentation of ferulic acid-induced vasorelaxation with aging and its structure importance in thoracic aorta of spontaneously hypertensive rats. Naunyn Schmiedebergs Arch Pharmacol (2015) 0.75
The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science (1998) 39.86
Crystal structure of a mammalian voltage-dependent Shaker family K+ channel. Science (2005) 17.70
X-ray structure of a voltage-dependent K+ channel. Nature (2003) 14.50
Crystal structure and mechanism of a calcium-gated potassium channel. Nature (2002) 10.03
Effective energy function for proteins in solution. Proteins (1999) 9.44
A graph-theory algorithm for rapid protein side-chain prediction. Protein Sci (2003) 9.25
Non-selective conductance in calcium channels of frog muscle: calcium selectivity in a single-file pore. J Physiol (1984) 8.20
Monte Carlo-minimization approach to the multiple-minima problem in protein folding. Proc Natl Acad Sci U S A (1987) 5.84
Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature (1983) 5.80
Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors. Nature (2001) 5.44
Principles of selective ion transport in channels and pumps. Science (2005) 3.24
Molecular determinants of drug binding and action on L-type calcium channels. Annu Rev Pharmacol Toxicol (1997) 2.06
Does the organic calcium channel blocker D600 act from inside or outside on the cardiac cell membrane? Pflugers Arch (1982) 1.90
Receptor sites for Ca2+ channel antagonists. Trends Pharmacol Sci (1992) 1.84
Molecular properties of calcium channels. Rev Physiol Biochem Pharmacol (1990) 1.44
Modeling P-loops domain of sodium channel: homology with potassium channels and interaction with ligands. Biophys J (2004) 1.40
1,4-Dihydropyridines as calcium channel ligands and privileged structures. Cell Mol Neurobiol (2003) 1.39
Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine. Proc Natl Acad Sci U S A (1991) 1.31
mu-conotoxin GIIIA interactions with the voltage-gated Na(+) channel predict a clockwise arrangement of the domains. J Gen Physiol (2000) 1.30
Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels. J Biol Chem (1995) 1.30
Potassium, sodium, calcium and glutamate-gated channels: pore architecture and ligand action. J Neurochem (2004) 1.26
Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels in transmembrane segment IIIS6 and the pore region of the alpha1 subunit. J Biol Chem (1997) 1.25
Access and binding of local anesthetics in the closed sodium channel. Mol Pharmacol (2008) 1.22
Voltage-dependent calcium channels. Gen Physiol Biophys (2005) 1.21
Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit. Proc Natl Acad Sci U S A (1991) 1.16
Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels. Proc Natl Acad Sci U S A (1990) 1.13
The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines. EMBO J (1996) 1.12
Mechanism of intracellular block of the KcsA K+ channel by tetrabutylammonium: insights from X-ray crystallography, electrophysiology and replica-exchange molecular dynamics simulations. J Mol Biol (2006) 1.12
Sodium channels: ionic model of slow inactivation and state-dependent drug binding. Biophys J (2007) 1.10
Molecular modeling of interactions of dihydropyridines and phenylalkylamines with the inner pore of the L-type Ca2+ channel. Mol Pharmacol (2003) 1.07
Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain. Biochem J (2000) 1.06
Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium. II. Pattern of inotropic effects of the optical isomers. Naunyn Schmiedebergs Arch Pharmacol (1975) 1.04
Structural model for dihydropyridine binding to L-type calcium channels. J Biol Chem (2009) 1.00
Modeling of the outer vestibule and selectivity filter of the L-type Ca2+ channel. Biochemistry (2001) 0.97
Calcium-channel drugs: structure-function relationships and selectivity of action. J Cardiovasc Pharmacol (1991) 0.95
Probing the architecture of an L-type calcium channel with a charged phenylalkylamine: evidence for a widely open pore and drug trapping. J Biol Chem (2006) 0.93
Relationship between the stereoselective negative inotropic effects of verapamil enantiomers and their binding to putative calcium channels in human heart. Br J Pharmacol (1985) 0.92
Extra- and intracellular action of quaternary devapamil on muscle L-type Ca(2+)-channels. Br J Pharmacol (1996) 0.90
Molecular modeling of benzothiazepine binding in the L-type calcium channel. J Biol Chem (2008) 0.89
Distinct effects of mutations in transmembrane segment IVS6 on block of L-type calcium channels by structurally similar phenylalkylamines. Mol Pharmacol (1996) 0.88
Extracellular localization of the benzothiazepine binding domain of L-type Ca2+ channels. Mol Pharmacol (1993) 0.88
Transfer of L-type calcium channel IVS6 segment increases phenylalkylamine sensitivity of alpha1A. J Biol Chem (1996) 0.88
State-dependent verapamil block of the cloned human Ca(v)3.1 T-type Ca(2+) channel. Mol Pharmacol (2006) 0.88
Kinetics and state-dependent effects of verapamil on cardiac L-type calcium channels. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.86
Investigations on the structure-activity relationships of verapamil. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.86
The benzazepine/benzothiazepine binding domain of the cardiac L-type Ca2+ channel is accessible only from the extracellular side. Pflugers Arch (1993) 0.84
Reversible Inhibition of Potassium Contractures by optical isomers of verapamil and D 600 on slow muscle fibres of the frog. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.83
Molecular determinants of frequency dependence and Ca2+ potentiation of verapamil block in the pore region of Cav1.2. Mol Pharmacol (2004) 0.83
On the role of Ca(2+)- and voltage-dependent inactivation in Ca(v)1.2 sensitivity for the phenylalkylamine (-)gallopamil. Circ Res (2001) 0.82
Coronary vasodilator and cardiac effects of optical isomers of verapamil in the dog. J Cardiovasc Pharmacol (1980) 0.82
Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heart. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.80
Effects of D-600 and its optical isomers on force of contraction in cat papillary muscles and guinea-pig auricles. Br J Pharmacol (1977) 0.79
Opposite effects of a single IIIS5 mutation on phenylalkylamine and dihydropyridine interaction with L-type Ca2+ channels. J Biol Chem (2004) 0.78
Importance of nitrile substitution for the Ca antagonistic action. Arch Pharm (Weinheim) (1986) 0.78
Cardiovascular effects of verapamil enantiomer combinations in conscious dogs. Eur J Pharmacol (1998) 0.76
Actions of R- and S-verapamil and nifedipine on rat vascular and intestinal smooth muscle. Auton Autacoid Pharmacol (2004) 0.76
K+ channel modulators for the treatment of neurological disorders and autoimmune diseases. Chem Rev (2008) 1.52
Molecular evidence for dual pyrethroid-receptor sites on a mosquito sodium channel. Proc Natl Acad Sci U S A (2013) 1.44
Modeling P-loops domain of sodium channel: homology with potassium channels and interaction with ligands. Biophys J (2004) 1.40
Potassium, sodium, calcium and glutamate-gated channels: pore architecture and ligand action. J Neurochem (2004) 1.26
Chromanol 293B binding in KCNQ1 (Kv7.1) channels involves electrostatic interactions with a potassium ion in the selectivity filter. Mol Pharmacol (2007) 1.24
Access and binding of local anesthetics in the closed sodium channel. Mol Pharmacol (2008) 1.22
Identification of a cluster of residues in transmembrane segment 6 of domain III of the cockroach sodium channel essential for the action of pyrethroid insecticides. Biochem J (2009) 1.21
Docking flexible ligands in proteins with a solvent exposure- and distance-dependent dielectric function. J Comput Aided Mol Des (2010) 1.15
Sodium channel activators: model of binding inside the pore and a possible mechanism of action. FEBS Lett (2005) 1.15
Architecture and pore block of eukaryotic voltage-gated sodium channels in view of NavAb bacterial sodium channel structure. Mol Pharmacol (2012) 1.14
Sodium channels: ionic model of slow inactivation and state-dependent drug binding. Biophys J (2007) 1.10
Identification of new batrachotoxin-sensing residues in segment IIIS6 of the sodium channel. J Biol Chem (2011) 1.00
Theoretical study of interaction of winter flounder antifreeze protein with ice. Protein Sci (2004) 1.00
Structural model for dihydropyridine binding to L-type calcium channels. J Biol Chem (2009) 1.00
In silico activation of KcsA K+ channel by lateral forces applied to the C-termini of inner helices. Biophys J (2004) 0.99
Atomic determinants of state-dependent block of sodium channels by charged local anesthetics and benzocaine. FEBS Lett (2006) 0.94
How batrachotoxin modifies the sodium channel permeation pathway: computer modeling and site-directed mutagenesis. Mol Pharmacol (2005) 0.91
Monte Carlo-energy minimization of correolide in the Kv1.3 channel: possible role of potassium ion in ligand-receptor interactions. BMC Struct Biol (2007) 0.91
Possible roles of exceptionally conserved residues around the selectivity filters of sodium and calcium channels. J Biol Chem (2010) 0.90
Molecular modeling of benzothiazepine binding in the L-type calcium channel. J Biol Chem (2008) 0.89
Potassium channel block by a tripartite complex of two cationophilic ligands and a potassium ion. Mol Pharmacol (2010) 0.89
A homology model of the pore domain of a voltage-gated calcium channel is consistent with available SCAM data. J Gen Physiol (2010) 0.86
Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists. Mol Pharmacol (2003) 0.85
KvAP-based model of the pore region of shaker potassium channel is consistent with cadmium- and ligand-binding experiments. Biophys J (2005) 0.84
Serine-401 as a batrachotoxin- and local anesthetic-sensing residue in the human cardiac Na+ channel. Pflugers Arch (2007) 0.84
Irreversible block of cardiac mutant Na+ channels by batrachotoxin. Channels (Austin) (2007) 0.84
Structural modeling of calcium binding in the selectivity filter of the L-type calcium channel. Eur Biophys J (2010) 0.83
Contrasting actions of philanthotoxin-343 and philanthotoxin-(12) on human muscle nicotinic acetylcholine receptors. Mol Pharmacol (2003) 0.83
Interaction of d-tubocurarine with potassium channels: molecular modeling and ligand binding. Mol Pharmacol (2006) 0.83
Docking of calcium ions in proteins with flexible side chains and deformable backbones. Eur Biophys J (2009) 0.81
Batrachotoxin, pyrethroids, and BTG 502 share overlapping binding sites on insect sodium channels. Mol Pharmacol (2011) 0.80
Mapping of steroids binding to 17 beta-hydroxysteroid dehydrogenase type 1 using Monte Carlo energy minimization reveals alternative binding modes. Biochemistry (2005) 0.80
State-dependent inter-repeat contacts of exceptionally conserved asparagines in the inner helices of sodium and calcium channels. Pflugers Arch (2014) 0.80
Uncompetitive antagonism of AMPA receptors: Mechanistic insights from studies of polyamine toxin derivatives. J Med Chem (2006) 0.80
Ligand action on sodium, potassium, and calcium channels: role of permeant ions. Trends Pharmacol Sci (2013) 0.79
The effects of conformational constraints in the polyamine moiety of philanthotoxins on AMPAR inhibition. ChemMedChem (2014) 0.78
Overlapping binding sites of structurally different antiarrhythmics flecainide and propafenone in the subunit interface of potassium channel Kv2.1. J Biol Chem (2010) 0.78
Why does the inner-helix mutation A413C double the stoichiometry of Kv1.3 channel block by emopamil but not by verapamil? Mol Pharmacol (2011) 0.77
Blockade of NMDA receptor channels by 9-aminoacridine and its derivatives. Neurosci Lett (2008) 0.77
Non-classical mechanism of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor channel block by fluoxetine. Eur J Neurosci (2014) 0.77
Interaction of local anesthetics with the K (+) channel pore domain: KcsA as a model for drug-dependent tetramer stability. Channels (Austin) (2013) 0.77
Argiotoxin in the closed AMPA receptor channel: experimental and modeling study. Biochemistry (2011) 0.77
Interaction of the BKCa channel gating ring with dendrotoxins. Channels (Austin) (2014) 0.76
Common binding site for externally and internally applied AMPA receptor channel blockers. J Mol Neurosci (2009) 0.76
Influence of external magnesium ions on the NMDA receptor channel block by different types of organic cations. Neuropharmacology (2012) 0.75
Voltage-dependent and -independent block of α-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor channels. J Neurochem (2010) 0.75
Investigation of structure-activity relationships in organophosphates-cholinesterase interaction using docking analysis. Chem Biol Interact (2010) 0.75